Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.

PubWeight™: 3.50‹?› | Rank: Top 1%

🔗 View Article (PMID 15604215)

Published in Endocrinology on December 16, 2004

Authors

Leila Khamzina1, Alain Veilleux, Sébastien Bergeron, André Marette

Author Affiliations

1: Department of Anantomy and Physiology and Lipid Research Unit, Laval University Hospital Research Center, 2705 Laurier boulevard, Ste-Foy, Québec, Canada G1V 4G2.

Articles citing this

(truncated to the top 100)

mTOR signaling in growth control and disease. Cell (2012) 29.21

Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell (2010) 10.96

Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell (2010) 7.59

The protein kinase IKKepsilon regulates energy balance in obese mice. Cell (2009) 3.93

Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell (2008) 3.91

Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci U S A (2007) 3.32

Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab (2007) 3.30

S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol Cell (2006) 3.25

Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat Cell Biol (2013) 3.11

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest (2011) 3.00

Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab (2011) 2.91

Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Invest (2007) 2.86

Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes (2010) 2.65

Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med (2012) 2.38

Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture. Oncotarget (2011) 2.28

mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab (2011) 2.28

Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci (2013) 2.22

The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy (2011) 2.18

Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia (2012) 2.05

S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2. J Biol Chem (2008) 1.85

Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice. Aging (Albany NY) (2012) 1.79

The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. J Neurosci (2008) 1.71

AMP-activated protein kinase signalling pathways are down regulated and skeletal muscle development impaired in fetuses of obese, over-nourished sheep. J Physiol (2008) 1.68

Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. Cell Metab (2012) 1.64

Neuronal regulation of homeostasis by nutrient sensing. Nat Med (2010) 1.61

Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res (2013) 1.56

Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation (2012) 1.56

Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci Signal (2012) 1.50

Targeting the CNS to treat type 2 diabetes. Nat Rev Drug Discov (2009) 1.45

NCI's provocative questions on cancer: some answers to ignite discussion. Oncotarget (2011) 1.42

Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to. Aging (Albany NY) (2012) 1.41

mTOR signaling for biological control and cancer. J Cell Physiol (2013) 1.40

Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function. Lipids Health Dis (2012) 1.32

Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis (2014) 1.30

Leucine supplementation of drinking water does not alter susceptibility to diet-induced obesity in mice. J Nutr (2009) 1.28

Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet. Aging Cell (2014) 1.27

Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol (2008) 1.25

Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation. Am J Physiol Endocrinol Metab (2011) 1.25

Improved insulin sensitivity by calorie restriction is associated with reduction of ERK and p70S6K activities in the liver of obese Zucker rats. J Endocrinol (2009) 1.20

mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis. Proc Natl Acad Sci U S A (2010) 1.20

The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Rep (2012) 1.16

Rapamycin-induced metabolic defects are reversible in both lean and obese mice. Aging (Albany NY) (2014) 1.12

The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature (2015) 1.11

Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann N Y Acad Sci (2011) 1.11

Gastric mammalian target of rapamycin signaling regulates ghrelin production and food intake. Endocrinology (2009) 1.10

mTOR Signaling in Growth, Metabolism, and Disease. Cell (2017) 1.10

Hormesis does not make sense except in the light of TOR-driven aging. Aging (Albany NY) (2011) 1.10

Proteome profile of functional mitochondria from human skeletal muscle using one-dimensional gel electrophoresis and HPLC-ESI-MS/MS. J Proteomics (2009) 1.09

Amino acids are necessary for the insulin-induced activation of mTOR/S6K1 signaling and protein synthesis in healthy and insulin resistant human skeletal muscle. Clin Nutr (2008) 1.08

Grb10 promotes lipolysis and thermogenesis by phosphorylation-dependent feedback inhibition of mTORC1. Cell Metab (2014) 1.07

Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives. Aging (Albany NY) (2010) 1.07

IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. Int J Mol Med (2008) 1.07

Inactivation of NF-kappaB p50 leads to insulin sensitization in liver through post-translational inhibition of p70S6K. J Biol Chem (2009) 1.06

Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes (2013) 1.05

AMPK exerts dual regulatory effects on the PI3K pathway. J Mol Signal (2010) 1.05

Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. J Biol Chem (2011) 1.05

Mammalian target of rapamycin signaling in diabetic cardiovascular disease. Cardiovasc Diabetol (2012) 1.04

Liver-specific p70 S6 kinase depletion protects against hepatic steatosis and systemic insulin resistance. J Biol Chem (2012) 1.04

TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists. Cell Death Dis (2013) 1.04

Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles of ob/ob mice. Am J Physiol Regul Integr Comp Physiol (2008) 1.03

AMPK and Exercise: Glucose Uptake and Insulin Sensitivity. Diabetes Metab J (2013) 1.03

The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney. Cardiorenal Med (2011) 1.01

Leptin signaling and circuits in puberty and fertility. Cell Mol Life Sci (2012) 1.01

Polysome profiling in liver identifies dynamic regulation of endoplasmic reticulum translatome by obesity and fasting. PLoS Genet (2012) 1.01

Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium. Cell Death Dis (2014) 1.01

Dietary effects on body composition, glucose metabolism, and longevity are modulated by skeletal muscle mitochondrial uncoupling in mice. Aging Cell (2010) 1.00

Lipid-induced mTOR activation in rat skeletal muscle reversed by exercise and 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside. J Endocrinol (2009) 1.00

Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice. J Biol Chem (2011) 0.97

A hepatic amino acid/mTOR/S6K-dependent signalling pathway modulates systemic lipid metabolism via neuronal signals. Nat Commun (2015) 0.96

L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin. J Biol Chem (2011) 0.96

Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression. J Biol Chem (2013) 0.96

High dietary protein intake, reducing or eliciting insulin resistance? Eur J Clin Nutr (2014) 0.95

Early responses of insulin signaling to high-carbohydrate and high-fat overfeeding. Nutr Metab (Lond) (2009) 0.95

In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes. Am J Physiol Endocrinol Metab (2010) 0.95

Altered regulation of contraction-induced Akt/mTOR/p70S6k pathway signaling in skeletal muscle of the obese Zucker rat. Exp Diabetes Res (2010) 0.95

mTORC1 signaling and regulation of pancreatic β-cell mass. Cell Cycle (2012) 0.94

mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging. Ann N Y Acad Sci (2015) 0.93

Koschei the immortal and anti-aging drugs. Cell Death Dis (2014) 0.93

Lipid biology of breast cancer. Biochim Biophys Acta (2013) 0.92

Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity. Diabetes (2014) 0.92

A chronic increase in physical activity inhibits fed-state mTOR/S6K1 signaling and reduces IRS-1 serine phosphorylation in rat skeletal muscle. Appl Physiol Nutr Metab (2008) 0.91

Muscle ectopic fat deposition contributes to anabolic resistance in obese sarcopenic old rats through eIF2α activation. Aging Cell (2014) 0.91

Restriction on an energy-dense diet improves markers of metabolic health and cellular aging in mice through decreasing hepatic mTOR activity. Rejuvenation Res (2015) 0.90

Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin. Biochim Biophys Acta (2014) 0.90

The evolution of insulin resistance in muscle of the glucose infused rat. Arch Biochem Biophys (2011) 0.90

Altered nutrient response of mTORC1 as a result of changes in REDD1 expression: effect of obesity vs. REDD1 deficiency. J Appl Physiol (1985) (2014) 0.89

NOX4 pathway as a source of selective insulin resistance and responsiveness. Arterioscler Thromb Vasc Biol (2012) 0.88

Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice. PLoS One (2014) 0.88

High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism. Hepatol Res (2011) 0.88

Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes--a potential model for PCOS-related insulin resistance. PLoS One (2009) 0.87

Comparison of rapamycin schedules in mice on high-fat diet. Cell Cycle (2014) 0.87

Recent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects. Trends Pharmacol Sci (2015) 0.85

Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation. J Lipid Res (2014) 0.85

The regulation of ApoB metabolism by insulin. Trends Endocrinol Metab (2013) 0.85

Regulation of Overnutrition-Induced Cardiac Inflammatory Mechanisms. Cardiorenal Med (2012) 0.84

Regulation of gastric hormones by systemic rapamycin. Peptides (2010) 0.84

Role and potential mechanisms of anabolic resistance in sarcopenia. J Cachexia Sarcopenia Muscle (2012) 0.84

Modulation of food intake by mTOR signalling in the dorsal motor nucleus of the vagus in male rats: focus on ghrelin and nesfatin-1. Exp Physiol (2013) 0.84

Exercise improves skeletal muscle insulin resistance without reduced basal mTOR/S6K1 signaling in rats fed a high-fat diet. Eur J Appl Physiol (2011) 0.82

Metabolic control by S6 kinases depends on dietary lipids. PLoS One (2012) 0.82

Articles by these authors

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab (2010) 4.08

Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci U S A (2007) 3.32

Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes (2010) 2.65

Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes (2005) 2.55

Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu Rev Nutr (2007) 2.03

Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J (2010) 1.71

Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology (2004) 1.71

Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv (2012) 1.60

Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC Cardiovasc Imaging (2011) 1.59

Visceral obesity and the heart. Int J Biochem Cell Biol (2007) 1.58

Cardioprotective effects of glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing coronary artery bypass grafting. J Clin Endocrinol Metab (2011) 1.57

Prognostic value of plasma B-type natriuretic peptide levels after exercise in patients with severe asymptomatic aortic stenosis. Heart (2014) 1.47

Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography. JACC Cardiovasc Imaging (2011) 1.44

The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nat Med (2006) 1.42

Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs. J Biol Chem (2004) 1.38

Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes (2010) 1.23

Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the Akt-mTOR-S6K1 pathway and insulin sensitivity. J Physiol (2006) 1.20

Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes (2010) 1.14

The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle. FASEB J (2003) 1.11

The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression. PLoS One (2010) 1.10

Androgen metabolism in adipose tissue: recent advances. Mol Cell Endocrinol (2008) 1.10

Stress echocardiography to assess stenosis severity and predict outcome in patients with paradoxical low-flow, low-gradient aortic stenosis and preserved LVEF. JACC Cardiovasc Imaging (2013) 1.08

Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1 promotes diet-induced hepatic steatosis and insulin resistance. Endocrinology (2009) 1.06

Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clin Endocrinol (Oxf) (2009) 1.04

Adjustments in cardiorespiratory function after pneumonectomy: results of the pneumonectomy project. J Thorac Cardiovasc Surg (2011) 1.01

Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis. Int J Cancer (2009) 1.01

The alpha-subunit of AMPK is essential for submaximal contraction-mediated glucose transport in skeletal muscle in vitro. Am J Physiol Endocrinol Metab (2008) 1.00

Endotoxin mediated-iNOS induction causes insulin resistance via ONOO⁻ induced tyrosine nitration of IRS-1 in skeletal muscle. PLoS One (2010) 0.99

Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1. Am J Physiol Endocrinol Metab (2011) 0.98

Validation of the use of peripheral blood mononuclear cells as surrogate model for skeletal muscle tissue in nutrigenomic studies. OMICS (2010) 0.98

Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Mol Endocrinol (2010) 0.97

Mitral valve cleft in both anterior and posterior leaflet: an extremely rare anomaly. Ann Thorac Surg (2006) 0.97

Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors. J Pharmacol Exp Ther (2005) 0.96

Modulation of insulin action by dietary proteins and amino acids: role of the mammalian target of rapamycin nutrient sensing pathway. Curr Opin Clin Nutr Metab Care (2005) 0.96

AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetes. PLoS One (2013) 0.94

Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. Diabetes (2008) 0.94

Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance. Diabetes (2011) 0.94

Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretion. J Lipid Res (2012) 0.92

Fish and marine omega-3 polyunsatured Fatty Acid consumption and incidence of type 2 diabetes: a systematic review and meta-analysis. Int J Endocrinol (2013) 0.92

PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats. Am J Physiol Endocrinol Metab (2014) 0.91

Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance. Rev Endocr Metab Disord (2014) 0.90

Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in women. Metabolism (2009) 0.90

Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation. J Mol Cell Cardiol (2009) 0.90

Altered glucose homeostasis in mice lacking the receptor protein tyrosine phosphatase sigma. Can J Physiol Pharmacol (2006) 0.89

Induction of insulin resistance by high-sucrose feeding does not raise mean arterial blood pressure but impairs haemodynamic responses to insulin in rats. Br J Pharmacol (2002) 0.88

Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity. Metabolism (2009) 0.88

Long-term physiological consequences of pneumonectomy. Semin Thorac Cardiovasc Surg (2011) 0.87

Prevention of oxidative stress, inflammation and mitochondrial dysfunction in the intestine by different cranberry phenolic fractions. Clin Sci (Lond) (2015) 0.86

Effects of a supplementation of n-3 polyunsaturated fatty acids with or without fish gelatin on gene expression in peripheral blood mononuclear cells in obese, insulin-resistant subjects. J Nutrigenet Nutrigenomics (2011) 0.86

Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of high-fat-fed obese rats. Diabetes (2003) 0.86

Splenic infarction associated with a mobile aortic valve lesion: a case report and review of the literature. Can J Cardiol (2009) 0.86

Differential effects of various fish proteins in altering body weight, adiposity, inflammatory status, and insulin sensitivity in high-fat-fed rats. Metabolism (2011) 0.86

The expression of FTO in human adipose tissue is influenced by fat depot, adiposity, and insulin sensitivity. Obesity (Silver Spring) (2013) 0.85

Hepatocyte-specific Ptpn6 deletion protects from obesity-linked hepatic insulin resistance. Diabetes (2012) 0.84

Compartmentalized CDK2 is connected with SHP-1 and β-catenin and regulates insulin internalization. Cell Signal (2011) 0.82

A variant in the LRRFIP1 gene is associated with adiposity and inflammation. Obesity (Silver Spring) (2013) 0.82

AMPK activation with AICAR provokes an acute fall in plasma [K+]. Am J Physiol Cell Physiol (2007) 0.81

Influence of estrogen on aortic stiffness and endothelial function in female rats. Am J Physiol Heart Circ Physiol (2002) 0.81

Anti-diabetic and antihypertensive activities of two flaxseed protein hydrolysate fractions revealed following their simultaneous separation by electrodialysis with ultrafiltration membranes. Food Chem (2013) 0.81

Irisin is more strongly predicted by muscle oxidative potential than adiposity in non-diabetic men. J Physiol Biochem (2015) 0.81

Fish nutrients decrease expression levels of tumor necrosis factor-alpha in cultured human macrophages. Physiol Genomics (2009) 0.81

A simple Doppler echocardiography method to evaluate pulmonary capillary wedge pressure in patients with atrial fibrillation. Echocardiography (2008) 0.81

Coronary ostia stenosis after transcatheter aortic valve implantation. JACC Cardiovasc Interv (2010) 0.81

Microarray-to-microarray transfer of reagents by snapping of two chips for cross-reactivity-free multiplex immunoassays. Anal Chem (2012) 0.81

Inducible nitric oxide synthase modulates lipolysis in adipocytes. J Lipid Res (2004) 0.80

Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic function. Can J Cardiol (2013) 0.79

Insulin activates RSK (p90 ribosomal S6 kinase) to trigger a new negative feedback loop that regulates insulin signaling for glucose metabolism. J Biol Chem (2013) 0.79

Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen species. Am J Physiol Endocrinol Metab (2010) 0.79

Impact of a lignan-rich diet on adiposity and insulin sensitivity in post-menopausal women. Br J Nutr (2009) 0.79

The role of protein tyrosine phosphatases in the regulation of allergic asthma: implication of TC-PTP and PTP-1B in the modulation of disease development. Immunology (2009) 0.78

Fatty acid-induced changes in vascular reactivity in healthy adult rats. Metabolism (2005) 0.78

Usefulness of an accelerated transoesophageal stress echocardiography in the preoperative evaluation of high risk severely obese subjects awaiting bariatric surgery. Cardiovasc Ultrasound (2010) 0.78

Predictors of cardiovascular fitness in sedentary men. Appl Physiol Nutr Metab (2009) 0.78

Anginal threshold between stress tests: exercise versus dobutamine stress echocardiography. Med Sci Sports Exerc (2005) 0.78

Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ. Hepatology (2014) 0.78

Effects of ethinyl estradiol, estradiol, and testosterone on hindlimb endothelial function in vivo. J Cardiovasc Pharmacol (2002) 0.78

Enhancement of glucose uptake in muscular cell by soybean charged peptides isolated by electrodialysis with ultrafiltration membranes (EDUF): activation of the AMPK pathway. Food Chem (2013) 0.78

Inhibition of the protein tyrosine phosphatase SHP-1 increases glucose uptake in skeletal muscle cells by augmenting insulin receptor signaling and GLUT4 expression. Endocrinology (2011) 0.78

Influence of left ventricular filling pattern on exercise-induced changes of natriuretic peptides in patients with suspected coronary artery disease. Int J Cardiol (2007) 0.77

Transcriptomic profiles of skeletal muscle tissue following an euglycemic-hyperinsulinemic clamp in insulin-resistant obese subjects. Genes Nutr (2012) 0.76

Safety of the cardiac triple therapy: the experience of the Quebec Heart Institute. Can J Cardiol (2007) 0.75

Pheochromocytoma associated with apical-sparing left ventricular dysfunction due to acute afterload mismatch: a novel clinical entity? Can J Cardiol (2007) 0.75

Omega-3 fatty acids protect from diet-induced obesity, glucose intolerance, and adipose tissue inflammation through PPARγ-dependent and PPARγ-independent actions. Mol Nutr Food Res (2015) 0.75

Adult Bland-White-Garland syndrome presenting as cardiomyopathy characterized by subendocardial fibrosis. J Am Coll Cardiol (2010) 0.75

Distinct metabolic and vascular effects of dietary triglycerides and cholesterol in atherosclerotic and diabetic mouse models. Am J Physiol Endocrinol Metab (2013) 0.75

Acute vascular effects of the selective estrogen receptor modulator EM-652 (SCH 57068) in the rat mesenteric vascular bed. Cardiovasc Res (2003) 0.75

Cardiorespiratory fitness and components of the metabolic syndrome in sedentary men. Obes Facts (2009) 0.75

Images in cardiovascular medicine: transapical aortic valve implantation in a patient with severe aortic stenosis and Pott disease. Circulation (2009) 0.75

Reduction of endothelial NOS and bradykinin-induced extravasation of macromolecules in skeletal muscle of the fructose-fed rat model. Cardiovasc Res (2003) 0.75

New insights in covalent modifications of proteins and lipids: phosphorylation and beyond. Am J Physiol Endocrinol Metab (2009) 0.75